A5062565562- Computational Drug Discovery Methods
- Psoriasis: Treatment and Pathogenesis
- Pharmacogenetics and Drug Metabolism
- Biosimilars and Bioanalytical Methods
Advanced Numerical Research and Analysis Group
2023
Plaque psoriasis is a common, long-lasting illness that affects the immune system and causes significant negative impacts on patient's physical health, well-being, ability to work effectively. Deucravacitinib (DEU) first oral medication used in treatment of plaque psoriasis, chronic skin condition red, scaly patches skin. DEU type called an Janus kinase (JAK) inhibitor, which works by blocking specific enzymes play role inflammation response associated with psoriasis. Therefore, quick, easy,...
Plaque psoriasis is a common, long-lasting illness that affects the immune system and causes significant negative impacts on patient's physical health, well-being, ability to work effectively. Deucravacitinib (DEU) first oral medication used in treatment of plaque psoriasis, chronic skin condition red, scaly patches skin. DEU type called an Janus kinase (JAK) inhibitor, which works by blocking specific enzymes play role inflammation response associated with psoriasis. Therefore,...